Wanted: Leadership

In the wake of Chris Christie and Rand Paul pandering to the anti-vaccine crowd using bankrupt personal liberty rhetoric (coherent libertarian ideology requires one to admit that externalities* exist), Sarah Despres, former Congressional staffer, connects Congress’ abdication of leadership on the vital health initiative of vaccinations for political expediency to the current revival of measles as something parents have to fear:

Few legislators were prepared to stand up for science…As for the others, the antivaccine evidence presented might have been shaky, but the science is complicated. And most members of Congress — on the committee and off — did not feel comfortable opposing the advocates and parents armed with heartbreaking stories of children whose autism seemed to come on just after they received their routine immunizations.
-Sarah Despres in Politico Magazine

*The economic version of the basic concept parents not named Ron Paul teach their children that their actions affect other people and that you are responsible for the effects of those actions.


Filed under: This Mortal Coil Tagged: congress, immunization, Linkonomicon, Politico, Sarah Despres, Vaccination, vaccines

Why Measles Isn’t Just An Anti-Vaxxer Problem

I have a little metaphor I use with my kid. When he asks why we get shots at the doctor, I remind him of all the super powers he has. One day he got super powers against whooping cough and … Continue reading »

The post Why Measles Isn’t Just An Anti-Vaxxer Problem appeared first on PLOS Blogs Network.

Replication Is Key: Revisting the Hypnagogic Jab

You may remember a two-part article I wrote last January on the very complex issue of whether or not a particular H1N1 vaccine might have caused new cases of narcolepsy.

Toward the end of the second part, I wrote the following two paragraphs:

“The group which recently reported on this hypocretin-targeting white blood cell tested the H1N1 virus, to see if the same blood cell that recognizes hypocretin as ‘bad’ would act similarly for parts of the H1N1 influenza virus itself. Lo and behold, they did find that part of the virus triggered a similar reaction in this highly specialized cell. This is one more piece of evidence pointing in the direction that infectious agents may trigger the onset of narcolepsy in genetically-predisposed individuals.

The Nature News piece that summarized these recent findings had a great quote from Gert Lammers, a neurologist working at Leiden University Medical Center in the Netherlands: ‘The results are very important, but they need to do a replication study in a large group of patients and controls.’7 Indeed, while this is all very exciting, replication in science is key. When one paper demonstrates that A leads to B, the public should say, ‘Hmm, interesting.’ When four independent papers demonstrate the same thing, it’s time to pop the cork on the champagne bottle.”

Wouldn’t you know?

The paper whose results I was quoting above has just been retracted by the journal which published it, Science Translational Medicine.

From a Nature blog on the retraction:

“But on 31 July, the authors announced that they have been unable to repeat a key finding: that immune cells from people with narcolepsy respond to hypocretin more so than immune cells from people who do not have narcolepsy. ‘Because the validity of the conclusions reported in the study cannot be confirmed, we are retracting the article,’ the team wrote.”

You can read the full post here.

This should serve as another reminder that one paper showing a correlation is interesting. Four independent papers demonstrating the same correlation, that’s something.

Replication is key.


Vaccine Memories: From Polio to Autism

Salk_Thank_You“April 15 – Polio Vaccine Perfected!!!!”

So wrote my mother in 1955, on the “Baby’s Health Record” page of my baby book. I unearthed it a few days ago while looking for some old writing clips.

Just a …

The post Vaccine Memories: From Polio to Autism appeared first on PLOS Blogs Network.

Bill and Melinda Gates want to give you $250,000 #Vaccines

All you have to do is apply and, well, win ... just got this email from the Gates Foundation - definitely worth nominating someone if you think they are doing good work.  Once again, the Gates Foundation is helping change the world ... Jenny McCarthy need not apply.  Here is the email:


Dear Colleagues:
Do you know someone who is improving vaccine delivery in the developing world? Now is the time to nominate that person or group of people for the second annual Gates Vaccine Innovation Award. Time is running out -- the deadline for nominations is August 31, 2012.
The Gates Vaccine Innovation Award is open to individuals from any discipline who work on the delivery of vaccines. Candidates from academic institutions, governments, health care facilities, research institutions, non-profit organizations and for-profit companies may be nominated.
We are looking for ideas, big or small, that have resulted in tangible improvements in immunization coverage in developing countries.
We invite you to nominate individuals or groups of individuals who have achieved significant improvements in the prevention, control, or elimination of vaccine preventable diseases through immunization.
The winning nomination will be recognized with a $250,000 award.
Read about the 2012 Gates Vaccine Innovation Award winner Dr. Asm Amjad Hossain here.
Thank you for your continued support of this important award. 


Selection in a putative meningitis vaccine target

In Variation of the factor H-binding protein in Neisseria meningitidis, Carina Brehony in Martin Maiden's lab at Oxford investigated a group of outer membrane proteins in the bacterium responsible for meningococcal meningitis. To date, attempts to raise a vaccine against the common serogroup B meningococci have been frustrated by the low immunogenicity of the serogroup B capsular polysaccharide, despite success with serogroups A and C. Outer membrane proteins, such as factor H-binding protein (fHbp) may provide alternative targets for vaccine development.

However, fHbp is genetically diverse, and our investigation showed evidence of structuring into three groups. OmegaMap analyses of the three groups revealed a signature consistent with strong selection pressure for antigenic variability at the gene. Notably, there was clear evidence of diversifying selection at several previously discovered epitopes - positions in the protein targeted by antibodies during bacteria-killing immune response. (Analysis of one group is shown in the figure, with known epitopes marked).

While these observations are encouraging in terms of understanding the biology of pathogen antigens, a pressing question is how do we translate that understanding into practical vaccine design? Studies such as ours suggest a multi-component vaccine may be necessary to achieve broad coverage against serogroup B meningococci.